NXL-001

N/A

Report date: 2024/11/08 10:19:02

Base Information

Drug NameNXL-001
Drug Alias NameNXL001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNeurogenic differentiation factor 1 stimulants
TargetsNeurogenic differentiation factor 1
Therapy Area/IndicationsAlzheimer DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuExcell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFujifilm CorpNeuExcell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A